Carregant...
Flow minimal residual disease monitoring of candidate leukemic stem cells defined by the immunophenotype, CD34(+)CD38(low)CD19(+) in B-lineage childhood acute lymphoblastic leukemia
Flow cytometric minimal residual disease (MRD) monitoring could become more powerful if directed towards the disease-maintaining leukemic stem cell (LSC) compartment. Using a cohort of 48 children with B-lineage acute lymphoblastic leukemia (ALL), we sought the newly proposed candidate-LSC populatio...
Guardat en:
| Autors principals: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Ferrata Storti Foundation
2010
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2857201/ https://ncbi.nlm.nih.gov/pubmed/19951974 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2009.011726 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|